Skip to main content

1 Result(s)

within Kelly Blinzler Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians

    The adoption of oncology biosimilars has been slow in the USA, which may be attributed in part to stakeholder perceptions and lack of operational guidance that supports favorable access to biosimilars.

    **gyan Yang, Kelly Blinzler, Joshua Lankin, Sapna Vijayakumar… in BioDrugs (2022)

    Download PDF (538 KB) View Article